TENAX THERAPEUTICS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability
TENAX THERAPEUTICS, INC. (TENX) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability of -$1.00 million as of 2014-04-30, per its 10-K filed 2014-07-29.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability · last filed 2014-07-29
- 2014-04-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability -$1.00M.
- 2014-01-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability -$1.00M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability |
|---|---|
| 2014-04-30 | -$1.00M 10-K · filed 2014-07-29 |
| 2014-01-31 | -$1.00M 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |